A NOVEL CATHETER ABLATION SYSTEM FOR ATRIAL FIBRILLATION USING UNIPOLAR AND BIPOLAR RADIOFREQUENCY ENERGY - SINGLE-CENTER REPORT ON 100 CONSECUTIVE PATIENTS  by Deneke, Thomas et al.
A6.E52
JACC March 9, 2010
Volume 55, issue 10A
  CARDIAC ARRHYTHMIAS 
A NOVEL CATHETER ABLATION SYSTEM FOR ATRIAL FIBRILLATION USING UNIPOLAR AND BIPOLAR 
RADIOFREQUENCY ENERGY - SINGLE-CENTER REPORT ON 100 CONSECUTIVE PATIENTS
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Clinical Electrophysiology--Supraventricular Arrhythmias
Abstract Category: Clinical Electrophysiology--Supraventricular Arrhythmias
Presentation Number: 1080-138
Authors: Thomas Deneke, Marc Horlitz, Ron Haberkorn, Annely Bastian, Kathrin Bünz, Markus Pässler, Beatrix Reinartz, Rainer Lehmann, Wolfgang 
Meuser, Dong-In Shin, Academic Heart Center Cologne, Cologne, Germany
Background: Catheter ablation of atrial fibrillation (AF) is increasingly used in experienced interventional electrophysiology centers. A novel 
ablation system using a decapolar circular ablation catheter (PVAC™, Ablation Frontiers) with the ability to create continuous lesions applied by uni- 
and bipolar radiofrequency (RF) energy has been developed. The acute and mid-term efficacy in treating AF is tested.
Methods: Consecutive patients with indication for AF catheter ablation were included and ablated using PVAC. Using the PVAC continuous nearly 
circular lesions can be produced. Procedural data was documented. Isolation of pulmonary veins (PVs) was tested under orciprenaline challenge and 
isolation of PVs was defined as absence of any PV potential inside the veins. Follow-up included EKG and holter-EKG (7 day monitoring).
Results: 100 patients (24 female, mean age 55±12years) were included (34 persistent, 66 paroxysmal). During ablation 390 out of 391 PVs (9pts 
with left common ostium) were successfully isolated with the PVAC (99.7%). Mean procedural duration was 104±25minutes, total RF application 
duration was 28±8minutes and radiation duration was 20.7±8.1minutes. Successful isolation was achieved with a median of 8±3 RF impulses for 
the left superior, 5±3 for the left inferior, 7±3for the right superior and 5±2 RF impulses for the right inferior PVs. For left common ostia a median of 
15±4 impulses led to electrical isolation. As procedural complications 2 aterio-venous fistulas and 1 reversible phrenic nerve palsy after isolation of 
the left superior caval vein was documented. In 4 (4%) patients esophageal erythema was identified after PV isolation procedures. During 6-months 
follow-up 80% of patients with paroxysmal AF and 50% of persistent AF patients were free from AF after undergoing PV-isolation alone.
Conclusions: PVAC-ablation is safe and effective in isolating the PVs. Short-term follow-up indicates rhythms success of over 75% of patients 
with paroxysmal AF. In persistent AF patients PV-isolation alone appears to be insufficient in producing stable sinus rhythm. Further studies need to 
evaluate mid- and long-term effect of PVAC ablation of AF on rhythm-outcome.
